Nova Eye Medical Completes Acquisition of Molteno Ophthalmology Assets
(WorldNews Health)

ASX / MEDIA RELEASE Nova Eye Medical Completes Acquisition of Molteno Ophthalmology Assets Adelaide, Australia, 3 August 2020 - Nova Eye Medical Limited (ASX: EYE)(Nova Eye Medical or the Company), a medical technology company committed to advanced ophthalmic treatment technologies and devices, today announces the completion of the acquisition of the Molteno3® glaucoma drainage device from Molteno Ophthalmic Limited (Molteno), a privately owned ophthalmology business based in Dunedin, New Zealand. As announced to the market on 2 July 2020, the Company has acquired the Molteno ophthalmology assets for a final cash consideration of...